A comparison of rate control and rhythm control in patients with atrial fibrillation.
By D. Wyse, A. Waldo, J. Dimarco, M. Domanski, Y. Rosenberg, Eleanor Schron, J. Kellen, H. Greene, M. Mickel, J. Dalquist and 1 more. New England Journal of Medicine, 2002
4,143 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine
View Paper: https://www.semanticscholar.org/paper/74a76043b056f65f39319dd670cff29631b4b80a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- G. Fonarow
- Stanley Nattel
- Gerhard Hindricks
- T. Horwich
- Ulrich Schotten
- A. Goette
- Paulus Kirchhof
- M. Ezekowitz
Citations in the corpus
- A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. (2006, result): “verall, in the present study, 23 patients (23%) discontined ADT because of adverse events, and these data compare ell to the 11% to 28% reported in the AFFIRM (Atrial ibrillation Follow-Up Investigation of Rhythm Manageent), CTAF (Canadian Trial of Atrial Fibrillation), and IAF (Rhythm or Rate Contr”
- Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (2010, methodology): “Previous guidelines recommended strict rate control aiming at a resting heart rate between 60–80 bpm and 90–115 bpm during moderate exercise, based on the type of therapy applied in the AFFIRM trial.(86) Strict rate control therapy required implantation of a pacemaker for symptomatic bradycardia in ”
- Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. (2013, background): ““first diagnosed”, paroxysmal, persistent or permanent) and d) improve its therapeuticmanagement through the combination of pharmacological [2,3], interventional [4,5] and surgical [6], strategies.”
- Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. (2005, neutral): “Cardiovascular risk factors Diabetes mellitus 187 (19) 232 (15) 186 (16) 336 (22) Hyperlipidemia 309 (32) 588 (40) 413 (36) 518 (34) Current smoker 181 (19) 204 (14) 128 (11) 120 (8) No regular exercise 484 (51) 596 (42) 488 (44) 785 (53) Family history of CAD 111 (14) 291 (23) 195 (20) 252 (20)”
- Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. (2011, background): “prognosis in AF patients (3, 244), underscoring the need”